<DOC>
	<DOCNO>NCT00805558</DOCNO>
	<brief_summary>The purpose study assess clinical microbiological effectiveness moxifloxacin compare combination ciprofloxacin - metronidazole , use adjunctive therapy scale root planning treatment advance chronic periodontitis .</brief_summary>
	<brief_title>Comparison Moxifloxacin With Ciprofloxacin/Metronidazole Patients With Chronic Periodontitis</brief_title>
	<detailed_description>Periodontitis endemic inflammatory disease cause mixed bacterial biofilm infection follow destruction tooth support tissue . Standard care consist lifelong mechanical removal biofilm . However , outcome variable . According recent EFP AAP review , adjunctive antimicrobial therapy may beneficial.However , bear mind Colombia report frequent presence Enterobacteriaceae ( Klebsiella Enterobacter ) subgingival plaque patient chronic periodontitis , response treatment may different.The enteric show resistance amoxicillin , amoxicillin / clavulanate , metronidazole tetracycline study conduct United States , Norway , Brazil Colombia.Although combination ciprofloxacin metronidazole recommend dental literature know publication demonstrate effectiveness periodontopathogens enteric present subgingival plaque subject chronic periodontitis.On hand , vitro study demonstrate effectiveness moxifloxacin periodontopathogens , aware clinical trial vitro study antibiotic resistance susceptibility enteric isolate subgingival plaque patient chronic periodontitis employ moxifloxacin .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>18 year age clinical radiographic sign severe ( CAL 5 mm ) chronic periodontitis . least 20 natural teeth situ pocket probe depth ( PPDs ) ≥ 5 mm minimum eight tooth sit willingness participate available time require participation 30 % teeth present must PPDs ) ≥ 4 mm insertion loss ≥ 5 mm evaluate experienced periodontist informed consent sign patient ( parent sibling ) show confirm assumed allergy hypersensitive skin reaction moxifloxacin , ciprofloxacin ( quinolones list `` summary product characteristic , Version Juli 2005 '' ) , metronidazole ( 5nitroimidazoles ingredient Flagyl® 400mg list `` summary product characteristic , Version Juli 2007 '' ) , systemic disease condition list mention `` summary product characteristic '' subject undergone antibiotic therapy three month start study interrogation Down 's syndrome know AIDS/HIV regularly take systemic medication affect periodontal condition , e.g . phenytoin , nifedipine , and/or steroid drug professional periodontal therapy 6 month prior baseline require antibiotic treatment dental appointment pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Chronic Periodontitis</keyword>
	<keyword>antibiotic</keyword>
</DOC>